These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33843820)

  • 21. Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.
    Sampedro F; de la Fuente Revenga M; Valle M; Roberto N; Domínguez-Clavé E; Elices M; Luna LE; Crippa JAS; Hallak JEC; de Araujo DB; Friedlander P; Barker SA; Álvarez E; Soler J; Pascual JC; Feilding A; Riba J
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):698-711. PubMed ID: 28525587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.
    Nunes AA; Dos Santos RG; Osório FL; Sanches RF; Crippa JA; Hallak JE
    J Psychoactive Drugs; 2016; 48(3):195-205. PubMed ID: 27230395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca.
    Galvão-Coelho NL; de Menezes Galvão AC; de Almeida RN; Palhano-Fontes F; Campos Braga I; Lobão Soares B; Maia-de-Oliveira JP; Perkins D; Sarris J; de Araujo DB
    J Psychopharmacol; 2020 Oct; 34(10):1125-1133. PubMed ID: 32648790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in spirituality among ayahuasca ceremony novice participants.
    Trichter S; Klimo J; Krippner S
    J Psychoactive Drugs; 2009 Jun; 41(2):121-34. PubMed ID: 19705674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.
    Lawn W; Hallak JE; Crippa JA; Dos Santos R; Porffy L; Barratt MJ; Ferris JA; Winstock AR; Morgan CJA
    Sci Rep; 2017 Nov; 7(1):15201. PubMed ID: 29123145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiences of encounters with ayahuasca--"the vine of the soul".
    Kjellgren A; Eriksson A; Norlander T
    J Psychoactive Drugs; 2009 Dec; 41(4):309-15. PubMed ID: 20235436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.
    Barbanoj MJ; Riba J; Clos S; Giménez S; Grasa E; Romero S
    Psychopharmacology (Berl); 2008 Feb; 196(2):315-26. PubMed ID: 18030450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy.
    Orsolini L; Chiappini S; Papanti D; Latini R; Volpe U; Fornaro M; Tomasetti C; Vellante F; De Berardis D
    Hum Psychopharmacol; 2020 May; 35(3):e2728. PubMed ID: 32220028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
    Heise CW; Brooks DE
    J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health status of ayahuasca users.
    Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
    Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
    Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R
    PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions.
    dos Santos RG
    J Psychoactive Drugs; 2013; 45(2):179-88. PubMed ID: 23909005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.
    Uthaug MV; Mason NL; Toennes SW; Reckweg JT; de Sousa Fernandes Perna EB; Kuypers KPC; van Oorsouw K; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2021 Jul; 238(7):1899-1910. PubMed ID: 33694031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
    Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA
    Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.
    Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL
    Psychol Med; 2020 Dec; 50(16):2655-2666. PubMed ID: 33143790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulatory effects of ayahuasca on personality structure in a traditional framework.
    Netzband N; Ruffell S; Linton S; Tsang WF; Wolff T
    Psychopharmacology (Berl); 2020 Oct; 237(10):3161-3171. PubMed ID: 32700023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users.
    Ramaekers JG; Mallaroni P; Kloft L; Reckweg JT; Toennes SW; van Oorsouw K; Mason NL
    J Cogn Neurosci; 2023 Sep; 35(9):1382-1393. PubMed ID: 37159257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.
    Leger RF; Unterwald EM
    J Psychopharmacol; 2022 Jan; 36(1):20-30. PubMed ID: 34519567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.